fluconazole has been researched along with Pregnancy in 113 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral fluconazole during the first trimester of pregnancy may be associated with unfavourable pregnancy outcomes." | 9.01 | The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. ( Jiang, CM; Jiang, HY; Zhang, X; Zhang, Z; Zhou, YY, 2019) |
| "The high prevalence of Candida infection, especially those due to non-albicans Candida species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes." | 8.12 | Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. ( Dunaiski, CM; Jung, H; Kock, MM; Peters, RPH, 2022) |
| "Within the Quebec Pregnancy Cohort (1998-2015), we identified women exposed to low- (≤ 150 mg) and high-dose (> 150 mg) fluconazole, and women who were not exposed." | 7.91 | Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. ( Abrahamowicz, M; Bérard, A; Bernatsky, S; de Moura, CS; Gorgui, J; Sheehy, O; Zhao, JP, 2019) |
| "In this nationwide cohort study in Denmark, use of oral fluconazole in pregnancy was associated with a statistically significant increased risk of spontaneous abortion compared with risk among unexposed women and women with topical azole exposure in pregnancy." | 7.83 | Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. ( Hviid, A; Melbye, M; Mølgaard-Nielsen, D; Pasternak, B; Svanström, H, 2016) |
| " She took a 150-mg dose of fluconazole 2 weeks ago for the treatment of vaginal candidiasis and she is worried about the effect on her child and pregnancy." | 7.81 | Fluconazole exposure during pregnancy. ( Bozzo, P; Kaplan, YC; Koren, G, 2015) |
| "Case reports suggest that long-term, high-dose fluconazole treatment for severe fungal infections during pregnancy causes a pattern of birth defects." | 7.79 | Use of oral fluconazole during pregnancy and the risk of birth defects. ( Hviid, A; Mølgaard-Nielsen, D; Pasternak, B, 2013) |
| "We evaluated pregnancy outcomes in 234 women exposed to fluconazole, 492 exposed to a topically administered azole preparation, 88 exposed to an oral azole preparation other than fluconazole, and 1629 not exposed to any of these agents during the first trimester of pregnancy Relative risks of having a baby with a congenital disorder for women exposed to fluconazole, oral azoles, and topical azoles in the first trimester of pregnancy compared with those who were unexposed were 1." | 7.70 | Pregnancy outcomes after maternal exposure to fluconazole. ( Jick, SS, 1999) |
| " We compared the pregnancy outcomes of 226 women exposed to fluconazole with that of 452 women exposed to nonteratogenic agents, with use of logistic regression to control for potential confounders." | 7.69 | Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. ( Botto, LD; Caramelli, L; Finardi, A; Fusco, D; Mastroiacovo, P; Mazzone, T; Serafini, MA, 1996) |
| "Recurrence is also more common in pregnant women, and therapeutic responses are reduced." | 5.38 | Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. ( Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S, 2012) |
| "A prescription-event monitoring (PEM) study has confirmed that fluconazole, a bis-triazole oral antifungal drug, is a safe and effective treatment for vaginal candidiasis." | 5.29 | Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy. ( Inman, W; Pearce, G; Wilton, L, 1994) |
| " Fluconazole during pregnancy may be associated with spontaneous abortion and craniofacial and heart defects." | 5.22 | Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. ( Brookhart, C; Lazenby, G; Nyirjesy, P; Schwebke, J; Sobel, JD, 2022) |
| "The study showed no increased risk of congenital malformations, low birth weight or preterm birth in offspring to women who had used single dose fluconazole before conception or during pregnancy." | 5.09 | Risk of malformations and other outcomes in children exposed to fluconazole in utero. ( Czeizel, AE; Larsen, H; Nielsen, GL; Olesen, C; Olsen, J; Schønheyder, HC; Sorensen, HT; Steffensen, FH, 1999) |
| " Five were exposed to 200-800 mg fluconazole during pregnancy." | 5.05 | Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management. ( Boulware, DR; Evans, EE; Meya, DB; Muzoora, C; Nalintya, E; Ndyetukira, JF; Nuwagira, E; Pastick, KA; Rajasingham, R; Rhein, J; Skipper, C; Ssebambulidde, K; Stephens, N; Tugume, L, 2020) |
| " The oral antifungal agents used during pregnancy were fluconazole and itraconazole." | 5.05 | Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: A systematic review and meta-analysis. ( Liu, D; Wu, L; Zhang, C; Zhang, L, 2020) |
| "Oral fluconazole during the first trimester of pregnancy may be associated with unfavourable pregnancy outcomes." | 5.01 | The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. ( Jiang, CM; Jiang, HY; Zhang, X; Zhang, Z; Zhou, YY, 2019) |
| " Because half of all pregnancies are unplanned and pregnant women have an increased risk of VVC recurrence, the likelihood of inadvertently being exposed to fluconazole in pregnancy is increased." | 4.91 | Exposure to fluconazole and risk of congenital malformations in the offspring: A systematic review and meta-analysis. ( Alsaad, AM; Kaplan, YC; Koren, G, 2015) |
| "The high prevalence of Candida infection, especially those due to non-albicans Candida species that are resistant to fluconazole, is a great concern in our setting and may lead to poor treatment outcomes." | 4.12 | Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia. ( Dunaiski, CM; Jung, H; Kock, MM; Peters, RPH, 2022) |
| "Use of fluconazole and topical azoles was established by requiring one or more prescriptions during the first trimester of pregnancy." | 3.96 | Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. ( Bateman, BT; Gray, KJ; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Straub, L; Zhu, Y, 2020) |
| "Within the Quebec Pregnancy Cohort (1998-2015), we identified women exposed to low- (≤ 150 mg) and high-dose (> 150 mg) fluconazole, and women who were not exposed." | 3.91 | Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. ( Abrahamowicz, M; Bérard, A; Bernatsky, S; de Moura, CS; Gorgui, J; Sheehy, O; Zhao, JP, 2019) |
| " Information on fluconazole use in early pregnancy was collected by self-report from 31,645 mothers of birth defect cases and 11,612 mothers of unaffected controls." | 3.83 | Fluconazole use and birth defects in the National Birth Defects Prevention Study. ( Browne, ML; Carter, TC; Cunniff, CM; Druschel, CM; Howley, MM; Romitti, PA, 2016) |
| "In this nationwide cohort study in Denmark, use of oral fluconazole in pregnancy was associated with a statistically significant increased risk of spontaneous abortion compared with risk among unexposed women and women with topical azole exposure in pregnancy." | 3.83 | Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth. ( Hviid, A; Melbye, M; Mølgaard-Nielsen, D; Pasternak, B; Svanström, H, 2016) |
| " She took a 150-mg dose of fluconazole 2 weeks ago for the treatment of vaginal candidiasis and she is worried about the effect on her child and pregnancy." | 3.81 | Fluconazole exposure during pregnancy. ( Bozzo, P; Kaplan, YC; Koren, G, 2015) |
| "Case reports suggest that long-term, high-dose fluconazole treatment for severe fungal infections during pregnancy causes a pattern of birth defects." | 3.79 | Use of oral fluconazole during pregnancy and the risk of birth defects. ( Hviid, A; Mølgaard-Nielsen, D; Pasternak, B, 2013) |
| "We found no overall increased risk of congenital malformations after exposure to short-course treatment with fluconazole in early pregnancy." | 3.74 | Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. ( Erichsen, R; Gislum, M; Nørgaard, M; Pedersen, L; Schønheyder, HC; Søgaard, KK; Sørensen, HT, 2008) |
| " We encountered a tuboovarian abscess caused by Candida glabrata after chemotherapy with an anticancer drug, methotrexate, in a febrile neutropenic patient." | 3.72 | Tuboovarian abscess caused by Candida glabrata in a febrile neutropenic patient. ( Mikamo, H; Ninomiya, M; Tamaya, T, 2003) |
| "We evaluated pregnancy outcomes in 234 women exposed to fluconazole, 492 exposed to a topically administered azole preparation, 88 exposed to an oral azole preparation other than fluconazole, and 1629 not exposed to any of these agents during the first trimester of pregnancy Relative risks of having a baby with a congenital disorder for women exposed to fluconazole, oral azoles, and topical azoles in the first trimester of pregnancy compared with those who were unexposed were 1." | 3.70 | Pregnancy outcomes after maternal exposure to fluconazole. ( Jick, SS, 1999) |
| " However, patients with this phenotype have been reported with a new dominant mutation at the FGFR2 locus as well as in the offspring of mothers taking the antifungal agent fluconazole during early pregnancy." | 3.70 | Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? ( Adès, L; Baraitser, M; Das, D; DeLozier-Blanchet, C; Hindmarsh, P; Honour, JW; Kelly, T; Kumar, D; Malcolm, S; McKee, S; McKeehan, WL; Nelson, I; Reardon, W; Rumsby, G; Sillence, D; Smith, A; Winter, RM, 2000) |
| " We compared the pregnancy outcomes of 226 women exposed to fluconazole with that of 452 women exposed to nonteratogenic agents, with use of logistic regression to control for potential confounders." | 3.69 | Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. ( Botto, LD; Caramelli, L; Finardi, A; Fusco, D; Mastroiacovo, P; Mazzone, T; Serafini, MA, 1996) |
| " Other topics included an outline of the World Health Organization's (WHO) stepped-care strategy for pain management, a discussion on the benefits of fluconazole prophylaxis in treating opportunistic infections, and the need to confirm self-reported HIV infection to avoid the problem of some people attempting to gain a secondary benefit by claiming to be HIV-positive." | 3.69 | First women's HIV conference hears go-for-broke antiretroviral strategy. ( Mascolini, M, 1995) |
| " In December 2022, Ibrexafungerp received FDA approval for once monthly dosing to decrease the incidence of RVVC." | 3.01 | Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy. ( Merjanian, L; Phillips, NA; Rocktashel, M, 2023) |
| "Fluconazole is a bis-triazole agent used in the treatment of superficial and systemic fungal infections, with vaginal candidiasis being one of the commonest indications to fluconazole treatment." | 2.72 | Maternal use of fluconazole and congenital malformations in the progeny: A meta-analysis of the literature. ( Budani, MC; Di Marzio, M; Fensore, S; Tiboni, GM, 2021) |
| "Fluconazole (FCZ) is an antifungal bis-triazole with potent inhibitory effect on the principal CYP-dependent metabolic pathway of PHT." | 2.69 | Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin. ( Bellati, U; Di Ilio, C; Giampietro, F; Iammarrone, E; Lamonaca, D; Tiboni, GM, 1999) |
| "Fluconazole was replaced in both twins by liposomal amphotericin B and the incubators were changed." | 2.55 | Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature. ( Astruc, D; Candolfi, E; Denis, J; Dillenseger, L; Gallais, F; Herbrecht, R; Koobar, O; Letscher-Bru, V; Sabou, M, 2017) |
| "The aim of this study was to build and verify a preliminary physiologically based pharmacokinetic (PBPK) model of Chinese pregnant women." | 1.56 | Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women. ( Li, X; Liu, D; Liu, X; Song, L; Xu, Y; Yu, Z; Zhou, T, 2020) |
| "If left untreated, vulvovaginal candidiasis (VVC) can lead to chorioamnionitis with subsequent abortion, prematurity and congenital infection of the neonate." | 1.56 | Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. ( Afeke, I; Agede, CY; Asiamah, EA; Deku, JG; Dodoo, C; Kasu, ES; Korbuvi, J; Kwawu, GS; Louis, B; Mbroh, HK; Mensah, P; Opintan, JA; Osei, GY; Tampuori, J; Waikhom, SD, 2020) |
| "Fluconazole (FLCZ) is an azole antifungal agent and it has shown excellent clinical activities in suppressing fungemia with Candida albicans after hematopoietic stem cell transplantation." | 1.48 | Breakthrough Candida guilliermondii (Meyerozyma guilliermondii) fungemia after cord blood transplantation for extranodal NK-cell lymphoma with azole prophylaxis. ( Ishida, F; Ito, T; Kikuchi, K; Nakazawa, H; Nishina, S; Sakai, H; Senoo, Y, 2018) |
| "Fluconazole treatment in utero decreased intestinal C." | 1.43 | Intra-amniotic Candida albicans infection induces mucosal injury and inflammation in the ovine fetal intestine. ( Hornef, MW; Jacobs, EM; Janssen, LE; Jobe, AH; Kallapur, SG; Kemp, MW; Kramer, BW; Newnham, JP; Nikiforou, M; Payne, MS; Saito, M; Wolfs, TG, 2016) |
| "Fluconazole treatment temporarily decreased the pulmonary and chorioamnion inflammatory responses." | 1.42 | Fluconazole treatment of intrauterine Candida albicans infection in fetal sheep. ( Jobe, AH; Kallapur, SG; Kemp, MW; Kramer, BW; Maneenil, G; Miura, Y; Newnham, JP; Payne, MS; Senthamarai Kannan, P, 2015) |
| "Intra-amniotic Candida infection is associated with preterm rupture of membranes, preterm labor, severe neonatal infection, and fetal death." | 1.39 | Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection. ( Bean, LM; Beiswenger, TR; Dobak, WJ; Jackson, JR; Thorp, JA, 2013) |
| " Long-term administration of oral fluconazole was well accepted and effective at treating the multifocal C." | 1.39 | Multifocal Cryptococcus neoformans var. neoforms: infection, treatment, and monitoring by serial computed tomography in a Schmidt's red-tailed guenon (Cercopithecus ascanius schmidti). ( Adkesson, MJ; Colegrove, KM; Delaney, MA; Langan, JN; Muhlbauer, MC; Nevitt, BN; Rubin, DA, 2013) |
| "The patient with cryptococcal meningitis was treated with amphotericin B and fluconazole and the patient with cerebral aspergilloma with voriconazole." | 1.38 | Two rare cases of central nervous system opportunistic mycoses. ( Baršić, B; Mlinarić Missoni, E, 2012) |
| "Recurrence is also more common in pregnant women, and therapeutic responses are reduced." | 1.38 | Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. ( Aydin, M; Güzel, AB; Ilkit, M; Kalkanci, A; Khalil, II; Kuştimur, S, 2012) |
| "Fenticonazole was assessed by European Committee on Antimicrobial Susceptibility Testing and CLSI microdilution methods for the first time, and the results showed excellent agreement (97%) and significant interclass correlation coefficient (P < 0." | 1.35 | Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes. ( Alexopoulos, EC; Antonopoulou, S; Aoun, M; Baka, S; Grigoriou, O; Kalambokas, T; Kouskouni, E; Logothetis, E; Papadias, K; Velegraki, A; Zannos, A, 2009) |
| "Co-administration of NVP and daily dosage of FLU (200 mg/day and 400 mg/day) results in markedly increased trough plasma NVP level when compared to the administration of NVP alone." | 1.34 | Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole. ( Athichathanabadi, C; Manosuthi, W; Phoorisri, T; Sungkanuparph, S; Uttayamakul, S, 2007) |
| " Dose-response relationship was investigated by treating animals with 0 (vehicle), 87." | 1.33 | Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence. ( Giampietro, F; Tiboni, GM, 2005) |
| "The pregnancy was complicated by maternal human immunodeficiency virus (HIV) infection and multiple drug exposures, including fluconazole (400 mg/day) until the fifth month and then from 6 months to term, efavirenz, nevirapine, methadone, dapsone, pentamidine, and trimethoprim-sulfamethoxazole." | 1.33 | Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. ( Lopez-Rangel, E; Van Allen, MI, 2005) |
| "Fluconazole (FCZ) is a potent inhibitor of the cytochrome P450 (CYP)-mediated metabolism of the anti-epileptic agent phenytoin (PHT), a well-known human and animal teratogen." | 1.32 | Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole. ( Angelucci, S; Bellati, U; Di Ilio, C; Giampietro, F; Moio, P; Tiboni, GM, 2003) |
| "A prescription-event monitoring (PEM) study has confirmed that fluconazole, a bis-triazole oral antifungal drug, is a safe and effective treatment for vaginal candidiasis." | 1.29 | Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy. ( Inman, W; Pearce, G; Wilton, L, 1994) |
| "Fluconazole has been associated with various teratisms in animals, including craniofacial ossification defects, thin, wavy ribs, and renal pelvis defects." | 1.29 | Fluconazole-induced congenital anomalies in three infants. ( Abraham, J; Andersen, HF; Bartley, JA; Blomquist, IK; Pursley, TJ, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.88) | 18.7374 |
| 1990's | 18 (15.93) | 18.2507 |
| 2000's | 31 (27.43) | 29.6817 |
| 2010's | 44 (38.94) | 24.3611 |
| 2020's | 19 (16.81) | 2.80 |
| Authors | Studies |
|---|---|
| Antonopoulou, S | 1 |
| Aoun, M | 1 |
| Alexopoulos, EC | 1 |
| Baka, S | 1 |
| Logothetis, E | 1 |
| Kalambokas, T | 1 |
| Zannos, A | 1 |
| Papadias, K | 1 |
| Grigoriou, O | 1 |
| Kouskouni, E | 1 |
| Velegraki, A | 1 |
| Nyirjesy, P | 1 |
| Brookhart, C | 1 |
| Lazenby, G | 1 |
| Schwebke, J | 1 |
| Sobel, JD | 1 |
| Aleanizy, FS | 1 |
| Taha, EI | 1 |
| Salem-Bekhit, MM | 1 |
| Felimban, AMJ | 1 |
| Al-Suwayeh, SA | 1 |
| Al-Joufi, FA | 1 |
| Muharram, MM | 1 |
| Alqahtani, FY | 1 |
| Shakeel, F | 1 |
| Youssof, AME | 1 |
| Bayomi, M | 1 |
| Abouelela, AEF | 1 |
| de Souza, ANV | 1 |
| Faria, MGI | 1 |
| da Rocha, CE | 1 |
| Philippsen, GS | 1 |
| Silva, GCC | 1 |
| da Silva, GR | 1 |
| Inumaro, RS | 1 |
| Gonçalves, JE | 1 |
| Gazim, ZC | 1 |
| Wietzikoski, S | 1 |
| Lívero, FADR | 1 |
| Seixas, FAV | 1 |
| Wietzikoski Lovato, EC | 1 |
| Dunaiski, CM | 1 |
| Kock, MM | 1 |
| Jung, H | 1 |
| Peters, RPH | 1 |
| Sucher, AJ | 1 |
| Thai, A | 1 |
| Tran, C | 1 |
| Mantena, N | 1 |
| Noronha, A | 1 |
| Chahine, EB | 1 |
| Bouglita, W | 1 |
| Rabhi, S | 1 |
| Raich, N | 1 |
| Bouabid, C | 1 |
| Belghith, C | 1 |
| Slimani, O | 1 |
| Hkimi, C | 1 |
| Ghedira, K | 1 |
| Karess, RE | 1 |
| Guizani-Tabbane, L | 1 |
| Attia, L | 1 |
| Rabhi, I | 1 |
| Metruccio, F | 3 |
| Battistoni, M | 3 |
| Di Renzo, F | 4 |
| Moretto, A | 3 |
| Menegola, E | 4 |
| Carvalho, GC | 2 |
| Marena, GD | 2 |
| Leonardi, GR | 2 |
| Sábio, RM | 2 |
| Corrêa, I | 2 |
| Chorilli, M | 2 |
| Bauab, TM | 2 |
| Pahwa, R | 1 |
| Ahuja, M | 1 |
| Phillips, NA | 1 |
| Rocktashel, M | 1 |
| Merjanian, L | 1 |
| Zhang, Z | 1 |
| Zhang, X | 1 |
| Zhou, YY | 1 |
| Jiang, CM | 1 |
| Jiang, HY | 1 |
| Toh, J | 1 |
| Snowball, V | 1 |
| Howley, MM | 2 |
| Pastick, KA | 1 |
| Nalintya, E | 1 |
| Tugume, L | 1 |
| Ssebambulidde, K | 1 |
| Stephens, N | 1 |
| Evans, EE | 1 |
| Ndyetukira, JF | 1 |
| Nuwagira, E | 1 |
| Skipper, C | 1 |
| Muzoora, C | 1 |
| Meya, DB | 1 |
| Rhein, J | 1 |
| Boulware, DR | 1 |
| Rajasingham, R | 1 |
| Liu, D | 2 |
| Zhang, C | 1 |
| Wu, L | 1 |
| Zhang, L | 2 |
| Ghaddar, N | 1 |
| Anastasiadis, E | 1 |
| Halimeh, R | 1 |
| Ghaddar, A | 1 |
| Dhar, R | 1 |
| AlFouzan, W | 1 |
| Yusef, H | 1 |
| El Chaar, M | 1 |
| Waikhom, SD | 1 |
| Afeke, I | 1 |
| Kwawu, GS | 1 |
| Mbroh, HK | 1 |
| Osei, GY | 1 |
| Louis, B | 1 |
| Deku, JG | 1 |
| Kasu, ES | 1 |
| Mensah, P | 1 |
| Agede, CY | 1 |
| Dodoo, C | 1 |
| Asiamah, EA | 1 |
| Tampuori, J | 1 |
| Korbuvi, J | 1 |
| Opintan, JA | 1 |
| Zhu, Y | 1 |
| Bateman, BT | 1 |
| Gray, KJ | 1 |
| Hernandez-Diaz, S | 1 |
| Mogun, H | 1 |
| Straub, L | 1 |
| Huybrechts, KF | 1 |
| Song, L | 1 |
| Yu, Z | 1 |
| Xu, Y | 1 |
| Li, X | 1 |
| Liu, X | 1 |
| Zhou, T | 1 |
| Budani, MC | 1 |
| Fensore, S | 1 |
| Di Marzio, M | 1 |
| Tiboni, GM | 5 |
| Bender, RA | 1 |
| Çalışkan, Ş | 1 |
| Önal, B | 1 |
| Aslancan, R | 1 |
| Çalışkan, E | 1 |
| Kusanovic, JP | 1 |
| Romero, R | 1 |
| Martinovic, C | 1 |
| Silva, K | 1 |
| Erez, O | 1 |
| Maymon, E | 1 |
| Díaz, F | 1 |
| Ferrer, F | 1 |
| Valdés, R | 1 |
| Córdova, V | 1 |
| Vargas, P | 1 |
| Nilo, ME | 1 |
| Le Cerf, P | 1 |
| Mogensen, DM | 1 |
| Pihl, MB | 1 |
| Skakkebæk, NE | 1 |
| Andersen, HR | 1 |
| Juul, A | 1 |
| Kyhl, HB | 1 |
| Swan, S | 1 |
| Kristensen, DM | 1 |
| Andersen, MS | 1 |
| Lind, DV | 1 |
| Jensen, TK | 1 |
| Gallais, F | 1 |
| Denis, J | 1 |
| Koobar, O | 1 |
| Dillenseger, L | 1 |
| Astruc, D | 1 |
| Herbrecht, R | 1 |
| Candolfi, E | 1 |
| Letscher-Bru, V | 1 |
| Sabou, M | 1 |
| Nakazawa, H | 1 |
| Nishina, S | 1 |
| Senoo, Y | 1 |
| Sakai, H | 1 |
| Ito, T | 1 |
| Kikuchi, K | 1 |
| Ishida, F | 1 |
| Pasternak, B | 4 |
| Wintzell, V | 1 |
| Furu, K | 1 |
| Engeland, A | 1 |
| Neovius, M | 1 |
| Stephansson, O | 1 |
| Brandão, LDS | 1 |
| Boniek, D | 1 |
| Resende Stoianoff, MA | 1 |
| da Mata, FMR | 1 |
| de Azevedo, PRM | 1 |
| Fernandes, JV | 1 |
| Andrade, VS | 1 |
| Paquette, VC | 1 |
| Elwood, C | 1 |
| Bérard, A | 1 |
| Sheehy, O | 1 |
| Zhao, JP | 1 |
| Gorgui, J | 1 |
| Bernatsky, S | 1 |
| de Moura, CS | 1 |
| Abrahamowicz, M | 1 |
| Kroeker, R | 1 |
| Chichester, L | 1 |
| Lee, GH | 1 |
| Worlien, JM | 1 |
| Hernández-Torres, A | 1 |
| García-Vázquez, E | 1 |
| Laso-Ortiz, A | 1 |
| Herrero-Martínez, JA | 1 |
| Gómez-Gómez, J | 1 |
| Mølgaard-Nielsen, D | 3 |
| Hviid, A | 3 |
| Ssali, A | 1 |
| Namukwaya, S | 1 |
| Bufumbo, L | 1 |
| Seeley, J | 1 |
| G Lalloo, D | 1 |
| Kamali, A | 1 |
| Parkes-Ratanshi, R | 1 |
| Nevitt, BN | 1 |
| Langan, JN | 1 |
| Adkesson, MJ | 1 |
| Delaney, MA | 1 |
| Rubin, DA | 1 |
| Muhlbauer, MC | 1 |
| Colegrove, KM | 1 |
| Vlachadis, N | 1 |
| Iliodromiti, Z | 1 |
| Vrachnis, N | 1 |
| Magee, LA | 1 |
| Margo, K | 1 |
| Waldman, L | 1 |
| Reddy, SB | 1 |
| Kassim, A | 1 |
| Dettloff, J | 1 |
| Reddy, VB | 1 |
| Pilmis, B | 1 |
| Jullien, V | 1 |
| Sobel, J | 1 |
| Lecuit, M | 1 |
| Lortholary, O | 1 |
| Charlier, C | 1 |
| Baptista, MI | 1 |
| Nona, J | 1 |
| Ferreira, M | 1 |
| Sampaio, I | 1 |
| Abrantes, M | 1 |
| Tomé, MT | 1 |
| Neto, MT | 1 |
| Barroso, R | 1 |
| Serelha, M | 1 |
| Virella, D | 1 |
| Alsaad, AM | 1 |
| Kaplan, YC | 2 |
| Koren, G | 2 |
| Maneenil, G | 1 |
| Payne, MS | 2 |
| Senthamarai Kannan, P | 1 |
| Kallapur, SG | 2 |
| Kramer, BW | 2 |
| Newnham, JP | 2 |
| Miura, Y | 1 |
| Jobe, AH | 2 |
| Kemp, MW | 2 |
| Bozzo, P | 1 |
| Carter, TC | 1 |
| Browne, ML | 1 |
| Romitti, PA | 1 |
| Cunniff, CM | 1 |
| Druschel, CM | 1 |
| Wise, J | 1 |
| Svanström, H | 1 |
| Melbye, M | 1 |
| Yang, L | 1 |
| Su, MQ | 1 |
| Ma, YY | 1 |
| Xin, YJ | 1 |
| Han, RB | 1 |
| Zhang, R | 1 |
| Wen, J | 1 |
| Hao, XK | 1 |
| Briglio, J | 1 |
| Nikiforou, M | 1 |
| Jacobs, EM | 1 |
| Hornef, MW | 1 |
| Saito, M | 1 |
| Janssen, LE | 1 |
| Wolfs, TG | 1 |
| Aschenbrenner, DS | 1 |
| Cassina, M | 1 |
| Cagnoli, GA | 1 |
| Zuccarello, D | 1 |
| Di Gianantonio, E | 1 |
| Clementi, M | 1 |
| Barzin, A | 1 |
| Mounsey, A | 1 |
| Tapia, CV | 1 |
| Hermosilla, G | 1 |
| Fortes, P | 1 |
| Alburquenque, C | 1 |
| Bucarey, S | 1 |
| Salinas, H | 1 |
| Rodas, PI | 1 |
| Díaz, MC | 1 |
| Magne, F | 1 |
| Fucic, A | 1 |
| Markovic, D | 1 |
| Herceg, Z | 1 |
| Gamulin, M | 1 |
| Katic, J | 1 |
| Stojkovic, R | 1 |
| Ferencic, Z | 1 |
| Mildner, B | 1 |
| Jazbec, AM | 1 |
| Dobranic, T | 1 |
| Nakamura, S | 1 |
| Izumikawa, K | 1 |
| Seki, M | 1 |
| Kakeya, H | 1 |
| Yamamoto, Y | 1 |
| Yanagihara, K | 1 |
| Miyazaki, Y | 1 |
| Kohno, S | 1 |
| Carey, JC | 1 |
| Martinez, L | 1 |
| Balken, E | 1 |
| Leen-Mitchell, M | 1 |
| Robertson, J | 1 |
| Pikuza, VV | 1 |
| Chilova, RA | 1 |
| Ishchenko, AI | 1 |
| Marotta, F | 1 |
| Carletti, E | 1 |
| Mudumbi, SV | 1 |
| Marinov, B | 3 |
| Schwentner, L | 1 |
| Wulff, C | 1 |
| Kreienberg, R | 1 |
| Herr, D | 1 |
| Kalkanci, A | 1 |
| Güzel, AB | 1 |
| Khalil, II | 1 |
| Aydin, M | 1 |
| Ilkit, M | 1 |
| Kuştimur, S | 1 |
| Lachhab, L | 1 |
| Rasmouni, K | 1 |
| Ait Ben Haddou, EH | 1 |
| Maamar, M | 1 |
| Seffar, M | 1 |
| Regragui, W | 1 |
| Benomar, A | 1 |
| Yahyaoui, M | 1 |
| Gomez-Moyano, E | 1 |
| Cid Lama, A | 1 |
| Fernández Ballesteros, MD | 1 |
| Lova Navarro, M | 1 |
| Vera Casaño, A | 1 |
| Crespo Erchiga, V | 1 |
| Mlinarić Missoni, E | 1 |
| Baršić, B | 1 |
| Bean, LM | 1 |
| Jackson, JR | 1 |
| Dobak, WJ | 1 |
| Beiswenger, TR | 1 |
| Thorp, JA | 1 |
| Bauters, TG | 1 |
| Dhont, MA | 1 |
| Temmerman, MI | 1 |
| Nelis, HJ | 1 |
| Broccia, ML | 1 |
| Giavini, E | 1 |
| Stenberg-Nilsen, H | 1 |
| Petkova, C | 1 |
| Kolarov, G | 2 |
| Georgiev, S | 1 |
| Iunakova, M | 1 |
| VAHLENKAMP, H | 1 |
| Mikamo, H | 1 |
| Ninomiya, M | 1 |
| Tamaya, T | 1 |
| Giampietro, F | 3 |
| Angelucci, S | 1 |
| Moio, P | 1 |
| Bellati, U | 2 |
| Di Ilio, C | 2 |
| Petkova, S | 1 |
| Konovalova, M | 1 |
| Laffitte, E | 1 |
| Genton, B | 1 |
| Panizzon, RG | 1 |
| Hsieh, WB | 1 |
| Leung, C | 1 |
| Lopez-Rangel, E | 1 |
| Van Allen, MI | 1 |
| Fellows, P | 1 |
| Rodrigo, N | 1 |
| Perera, KN | 1 |
| Ranwala, R | 1 |
| Jayasinghe, S | 1 |
| Warnakulasuriya, A | 1 |
| Hapuarachchi, S | 1 |
| Crawford, JT | 1 |
| Pereira, L | 1 |
| Buckmaster, J | 1 |
| Gravett, MG | 1 |
| Tolosa, JE | 1 |
| Manosuthi, W | 1 |
| Athichathanabadi, C | 1 |
| Uttayamakul, S | 1 |
| Phoorisri, T | 1 |
| Sungkanuparph, S | 1 |
| Annapureddy, SR | 1 |
| Masterson, SW | 1 |
| David, HG | 1 |
| Greig, JR | 1 |
| Benjamin, DK | 1 |
| Nørgaard, M | 1 |
| Pedersen, L | 1 |
| Gislum, M | 1 |
| Erichsen, R | 1 |
| Søgaard, KK | 1 |
| Schønheyder, HC | 2 |
| Sørensen, HT | 1 |
| Krcmery, S | 1 |
| Masar, O | 2 |
| Krcmery, V | 2 |
| Inman, W | 1 |
| Pearce, G | 1 |
| Wilton, L | 1 |
| Pursley, TJ | 1 |
| Blomquist, IK | 1 |
| Abraham, J | 1 |
| Andersen, HF | 1 |
| Bartley, JA | 1 |
| Huttova, M | 1 |
| Mastroiacovo, P | 1 |
| Mazzone, T | 1 |
| Botto, LD | 1 |
| Serafini, MA | 1 |
| Finardi, A | 1 |
| Caramelli, L | 1 |
| Fusco, D | 1 |
| Campomori, A | 1 |
| Bonati, M | 1 |
| Wray, CM | 1 |
| Baud, O | 1 |
| Boithias, C | 1 |
| Lacaze-Masmonteil, T | 1 |
| Ville, Y | 1 |
| Guibert, M | 1 |
| Zupan, V | 1 |
| Chabernaud, JL | 1 |
| André, P | 1 |
| Nordmann, P | 1 |
| Frydman, R | 1 |
| Dehan, M | 1 |
| Aleck, KA | 1 |
| Bartley, DL | 1 |
| Sanchez, JM | 1 |
| Moya, G | 1 |
| Albukrek, D | 1 |
| Davidson, S | 1 |
| Merlob, P | 1 |
| Jick, SS | 1 |
| Iammarrone, E | 1 |
| Lamonaca, D | 1 |
| Sorensen, HT | 1 |
| Nielsen, GL | 1 |
| Olesen, C | 1 |
| Larsen, H | 1 |
| Steffensen, FH | 1 |
| Olsen, J | 1 |
| Czeizel, AE | 1 |
| Reardon, W | 1 |
| Smith, A | 1 |
| Honour, JW | 1 |
| Hindmarsh, P | 1 |
| Das, D | 1 |
| Rumsby, G | 1 |
| Nelson, I | 1 |
| Malcolm, S | 1 |
| Adès, L | 1 |
| Sillence, D | 1 |
| Kumar, D | 1 |
| DeLozier-Blanchet, C | 1 |
| McKee, S | 1 |
| Kelly, T | 1 |
| McKeehan, WL | 1 |
| Baraitser, M | 1 |
| Winter, RM | 1 |
| Baleta, A | 1 |
| Busowski, JD | 1 |
| Safdar, A | 1 |
| Mascolini, M | 1 |
| Paz, A | 1 |
| Gonen, R | 1 |
| Potasman, I | 1 |
| Sikić, J | 1 |
| Vukojević, N | 1 |
| Katusić, D | 1 |
| Sarić, B | 1 |
| Laufer, B | 1 |
| Bender, HG | 1 |
| Lee, BE | 1 |
| Feinberg, M | 1 |
| Abraham, JJ | 1 |
| Murthy, AR | 1 |
| Arilla, MC | 1 |
| Carbonero, JL | 1 |
| Schneider, J | 1 |
| Regúlez, P | 1 |
| Quindós, G | 1 |
| Pontón, J | 1 |
| Cisterna, R | 1 |
15 reviews available for fluconazole and Pregnancy
| Article | Year |
|---|---|
Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Centers for Disease Control and Prev | 2022 |
Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy.
Topics: Antifungal Agents; Azoles; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; | 2023 |
The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Cra | 2019 |
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Cryptococcus neoform | 2020 |
Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: A systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Antifungal Agents; Case-Control Studies; Cohort Studies; Congenital Abnormali | 2020 |
Maternal use of fluconazole and congenital malformations in the progeny: A meta-analysis of the literature.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Antifungal Agents; Candidiasis, Vulvovaginal; Do | 2021 |
Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diseases in Twins; F | 2017 |
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacteria | 2013 |
Antifungal drugs during pregnancy: an updated review.
Topics: Administration, Intravenous; Administration, Topical; Amphotericin B; Anti-Infective Agents, Local; | 2015 |
Exposure to fluconazole and risk of congenital malformations in the offspring: A systematic review and meta-analysis.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis, Vulvovaginal; Craniofacial Abnormalitie | 2015 |
Pulmonary cryptococcosis in late pregnancy and review of published literature.
Topics: Adult; Antifungal Agents; Cryptococcosis; Diagnosis, Differential; Female; Fluconazole; Humans; Lung | 2009 |
Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Antirheumatic Agents; Congenital Abnormalities; Evid | 2009 |
Exacerbation of a maternal hiatus hernia in early pregnancy presenting with symptoms of hyperemesis gravidarum: case report and review of the literature.
Topics: Adult; Antifungal Agents; Candidiasis; Cesarean Section; Female; Fluconazole; Hernia, Hiatal; Humans | 2011 |
[Fluconazole administration during pregnancy].
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Female; Fluc | 1998 |
[Current developments in antimycotic therapy in gynecology and obstetrics].
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Flu | 1992 |
5 trials available for fluconazole and Pregnancy
| Article | Year |
|---|---|
Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?
Topics: Adult; Africa South of the Sahara; Antifungal Agents; Condoms; Condoms, Female; Contraception; Contr | 2013 |
[Comparison of clinical efficacy and safety of domestic generic and original fluconazoles in the treatment of pregnant women with vulvovaginal candidiasis].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drugs, Generic; Female; Fluconazole; Humans; Pr | 2008 |
[Some opportunities for the application of the drug mycosyst (preliminary communication)].
Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Female; Fluconazole; Humans; Middle Aged; Pregna | 2003 |
Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin.
Topics: Abnormalities, Drug-Induced; Animals; Anticonvulsants; Antifungal Agents; Body Weight; Cleft Palate; | 1999 |
Risk of malformations and other outcomes in children exposed to fluconazole in utero.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antifungal Agents; Denmark; Female; Fluconazole; Fol | 1999 |
93 other studies available for fluconazole and Pregnancy
| Article | Year |
|---|---|
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
Topics: Adult; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cluster Ana | 2009 |
Formulation and
Topics: Antifungal Agents; Delivery, Obstetric; Excipients; Female; Fluconazole; Gels; Humans; Nanogels; Pol | 2021 |
Bioactive compounds with antifungal activity against pathogens isolated from pregnant woman: Gallesia integrifolia (garlic wood) is a promising treatment for vulvovaginal candidiasis.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Vul | 2022 |
Importance of Candida infection and fluconazole resistance in women with vaginal discharge syndrome in Namibia.
Topics: Antifungal Agents; Candida; Candidiasis; Cross-Sectional Studies; Female; Fluconazole; Humans; Male; | 2022 |
Ibrexafungerp: A new triterpenoid antifungal.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Child; Echinocandins; Female; Fluconazole; Huma | 2022 |
Microbiological and molecular screening of
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans | 2022 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Moderate alcohol consumption during pregnancy increases potency of two different drugs (the antifungal fluconazole and the antiepileptic valproate) in inducing craniofacial defects: prediction by the in vitro rat whole embryo culture.
Topics: Alcohol Drinking; Animals; Anticonvulsants; Antifungal Agents; Ethanol; Female; Fluconazole; Humans; | 2023 |
Lycopene, Mesoporous Silica Nanoparticles and Their Association: A Possible Alternative against Vulvovaginal Candidiasis?
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; | 2022 |
Lycopene, Mesoporous Silica Nanoparticles and Their Association: A Possible Alternative against Vulvovaginal Candidiasis?
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; | 2022 |
Lycopene, Mesoporous Silica Nanoparticles and Their Association: A Possible Alternative against Vulvovaginal Candidiasis?
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; | 2022 |
Lycopene, Mesoporous Silica Nanoparticles and Their Association: A Possible Alternative against Vulvovaginal Candidiasis?
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; | 2022 |
Nanocellulose-gellan cross-linked scaffolds for vaginal delivery of fluconazole.
Topics: Delivery, Obstetric; Drug Delivery Systems; Female; Fluconazole; Humans; Polymers; Polysaccharides, | 2023 |
Postpartum sepsis caused by an intra-abdominal yeast infection.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Postpartum Per | 2020 |
Using meta-analyses to improve risk estimates of specific birth defects.
Topics: Female; Fluconazole; Humans; Pregnancy; Pregnancy Trimester, First; Risk Factors | 2019 |
Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovagi | 2020 |
Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilo | 2020 |
Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovagin | 2020 |
Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women.
Topics: Adult; Asian People; Aztreonam; Biological Transport; Ceftazidime; Ceftriaxone; Cefuroxime; Female; | 2020 |
Treatment methods for vulvovaginal candidiasis in pregnancy.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Pregnan | 2021 |
Transabdominal collection of amniotic fluid "sludge" and identification of Candida albicans intra-amniotic infection.
Topics: Adult; Amniocentesis; Amniotic Fluid; Antifungal Agents; Candida albicans; Candidiasis; Cervix Uteri | 2018 |
Prenatal exposure to antifungal medication may change anogenital distance in male offspring: a preliminary study.
Topics: Adult; Androgen Antagonists; Antifungal Agents; Denmark; Female; Fluconazole; Genitalia, Male; Human | 2017 |
Breakthrough Candida guilliermondii (Meyerozyma guilliermondii) fungemia after cord blood transplantation for extranodal NK-cell lymphoma with azole prophylaxis.
Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Candida; Candidemia; Candidiasis, Invasive; Cord B | 2018 |
Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death.
Topics: Administration, Oral; Antifungal Agents; Cohort Studies; Female; Fluconazole; Humans; Infant, Newbor | 2018 |
Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Brazil; Candida; Candida glabrata; Candidiasis | 2018 |
The safety of oral fluconazole therapy in pregnancy.
Topics: Antifungal Agents; Case-Control Studies; Female; Fluconazole; Pregnancy | 2019 |
Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.
Topics: Abortion, Spontaneous; Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulv | 2019 |
Effects of Pregnancy, Outdoor Access, and Antifungal Medication on Hair Loss in Breeding-age Female Pigtailed Macaques (
Topics: Age Factors; Alopecia; Animals; Antifungal Agents; Breeding; Coccidioidomycosis; Female; Fluconazole | 2019 |
Use of oral fluconazole during pregnancy and the risk of birth defects.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Adult; Antifungal Agents; Cohort Studies; Denmark | 2013 |
Multifocal Cryptococcus neoformans var. neoforms: infection, treatment, and monitoring by serial computed tomography in a Schmidt's red-tailed guenon (Cercopithecus ascanius schmidti).
Topics: Animals; Antifungal Agents; Cercopithecus; Cryptococcosis; Cryptococcus neoformans; Female; Fluconaz | 2013 |
Oral fluconazole during pregnancy and risk of birth defects.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Female; Fluconazole; Humans; Pregnancy | 2013 |
Oral fluconazole during pregnancy and risk of birth defects.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Female; Fluconazole; Humans; Pregnancy | 2013 |
ACP Journal Club. Fluconazole use during the first trimester of pregnancy was not associated with most major birth defects.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Female; Fluconazole; Humans; Pregnancy | 2014 |
Review: some clinical tests performed by specialists identify rotator cuff disease or tears.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Female; Fluconazole; Humans; Pregnancy | 2014 |
Neutrophilic Fixed Drug Eruption.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Drug Erupt | 2015 |
Invasive fungal infection in neonatal intensive care units: a multicenter survey.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Female; Fluconazole; Ge | 2016 |
Fluconazole treatment of intrauterine Candida albicans infection in fetal sheep.
Topics: Analysis of Variance; Animals; Antifungal Agents; Candidiasis; Female; Fetal Diseases; Fluconazole; | 2015 |
Fluconazole exposure during pregnancy.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Huma | 2015 |
Fluconazole use and birth defects in the National Birth Defects Prevention Study.
Topics: Abnormalities, Drug-Induced; Adult; Antifungal Agents; Candidiasis; Case-Control Studies; Female; Fl | 2016 |
Oral antifungal is associated with increased risk of miscarriage.
Topics: Abortion, Spontaneous; Antifungal Agents; Female; Fluconazole; Humans; Pregnancy; Stillbirth | 2016 |
Association Between Use of Oral Fluconazole During Pregnancy and Risk of Spontaneous Abortion and Stillbirth.
Topics: Abortion, Spontaneous; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ca | 2016 |
Epidemiology, species distribution, antifungal susceptibility, and ERG11 mutations of Candida species isolated from pregnant Chinese Han women.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fun | 2016 |
Oral fluconazole is often used during pregnancy in the treatment of vulvovaginal candidiasis despite safety concerns to the fetus.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fetus; Fluconazole; Huma | 2016 |
Intra-amniotic Candida albicans infection induces mucosal injury and inflammation in the ovine fetal intestine.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Chorioamnionitis; Cytokines; Female; Fetu | 2016 |
The FDA Reevaluates Oral Fluconazole Use in Pregnancy.
Topics: Abortion, Spontaneous; Administration, Oral; Antifungal Agents; Female; Fluconazole; Humans; Pregnan | 2016 |
Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
Topics: Abnormalities, Drug-Induced; Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fetal Diseas | 2017 |
PURLs: Yeast infection in pregnancy? Think twice about fluconazole.
Topics: Abortion, Spontaneous; Administration, Oral; Administration, Topical; Antifungal Agents; Azoles; Fem | 2016 |
Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvov | 2017 |
Developmental and transplacental genotoxicology: fluconazole.
Topics: Aging; Animals; Female; Fluconazole; Maternal-Fetal Exchange; Mice; Mice, Inbred BALB C; Micronucleu | 2008 |
Fluconazole alters CYP26 gene expression in mouse embryos.
Topics: Administration, Oral; Animals; Antifungal Agents; Cytochrome P-450 Enzyme System; Cytochrome P450 Fa | 2009 |
Disseminated cryptococcosis in an HIV-negative pregnancy: a case of cryptococcal septic abortion complicating an immunocompetent pregnancy.
Topics: Abortion, Septic; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; H | 2010 |
[Application of Pfizer drugs in the obstetrics and gynecology practice].
Topics: Anti-Bacterial Agents; Antifungal Agents; Cabergoline; Carboprost; Clindamycin; Dopamine Agonists; D | 2009 |
Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Boric Acids; Candida albicans; Candid | 2012 |
Fluconazole: teratogenicity.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Humans; Pregnancy; Pregnancy Complications, Infectiou | 2012 |
Cryptococcosis in an immunocompetent pregnant woman.
Topics: Adult; Amphotericin B; Antifungal Agents; Apgar Score; Brain; Cryptococcosis; Female; Fluconazole; H | 2013 |
[The Polish Gynecological Society Expert Committee recomendations regarding application of fluconazole in the treatment of vulvovaginal candidiasis].
Topics: Acute Disease; Administration, Topical; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Chron | 2012 |
[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis, Vulvovaginal; Cesarean Section; Drug Evalua | 2013 |
Two rare cases of central nervous system opportunistic mycoses.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus nidulans; Cryptococcus neoformans; Female; Flu | 2012 |
Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection.
Topics: Abruptio Placentae; Adult; Amnion; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Cesarean S | 2013 |
Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Contraceptives, Oral; Estrogen R | 2002 |
Pathogenic pathways in fluconazole-induced branchial arch malformations.
Topics: Animals; Antifungal Agents; Apoptosis; Branchial Region; Cell Division; Cell Movement; Embryonic and | 2003 |
[Use of fluconazole during pregnancy].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Fluconazole; | 2003 |
[On the subject of annular placenta. Report on a complete human zonal placenta with velamentous insertion of the umbilical cord].
Topics: Female; Fluconazole; Humans; Placenta; Placenta Diseases; Pregnancy; Umbilical Cord | 1961 |
Tuboovarian abscess caused by Candida glabrata in a febrile neutropenic patient.
Topics: Abscess; Adult; Amphotericin B; Antifungal Agents; Antimetabolites, Antineoplastic; Candida glabrata | 2003 |
Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole.
Topics: Animals; Chromatography, High Pressure Liquid; Cleft Palate; Dose-Response Relationship, Drug; Drug | 2003 |
[Three years experience of using mycosyst].
Topics: Abortion, Therapeutic; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Hum | 2004 |
Cutaneous leishmaniasis caused by Leishmania tropica: treatment with oral fluconazole.
Topics: Administration, Oral; Adult; Animals; Antifungal Agents; Diagnosis, Differential; Female; Fluconazol | 2005 |
Candidal arthritis after complete treatment of systemic candidiasis.
Topics: Amphotericin B; Antifungal Agents; Arthritis; Candidiasis; Diabetes, Gestational; Female; Fluconazol | 2005 |
Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence.
Topics: Abnormalities, Drug-Induced; Alcian Blue; Animals; Anthraquinones; Antifungal Agents; Body Weight; C | 2005 |
Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Antifungal Agents; Female; Fluconazole; HIV In | 2005 |
Medication in the wrong hands?
Topics: Antifungal Agents; Contraindications; Drug and Narcotic Control; Female; Fluconazole; Humans; Nonpre | 2005 |
Aspergillus meningitis following spinal anaesthesia for caesarean section in Colombo, Sri Lanka.
Topics: Abducens Nerve Diseases; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antifungal Agents; Aspe | 2007 |
Amniocentesis results and novel proteomic analysis in a case of occult candidal chorioamnionitis.
Topics: Adult; Amniocentesis; Antifungal Agents; Candidiasis; Chorioamnionitis; Female; Fluconazole; Humans; | 2006 |
Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole.
Topics: Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dru | 2007 |
Post partum osteomyelitis due to Cryptococcus neoformans.
Topics: Adult; Antifungal Agents; Cryptococcosis; Debridement; Female; Fluconazole; Humans; Injections, Intr | 2007 |
First, do no harm.
Topics: Antifungal Agents; Candidiasis; Developmental Disabilities; Female; Fluconazole; Humans; Incidence; | 2008 |
Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Candidiasis; Cohort Studies; Denmark; Female; Flucon | 2008 |
Nosocomial Torulopsis glabrata fungemia with shock in a pregnant woman successfully treated with high doses of fluconazole and delivery of healthy child.
Topics: Adult; Candida; Cross Infection; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Pregnancy; | 1995 |
Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Candidiasis, Vulvovaginal; Child; Child, Preschool; Drug | 1994 |
Fluconazole-induced congenital anomalies in three infants.
Topics: Abnormalities, Drug-Induced; Adult; Antifungal Agents; Bone and Bones; Coccidioidomycosis; Face; Fem | 1996 |
Teratogenicity of fluconazole.
Topics: Abnormalities, Drug-Induced; Adult; Antifungal Agents; Female; Fluconazole; Humans; Pregnancy | 1996 |
Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Cohort Studies; Female; Fluconazole; Humans; Pr | 1996 |
Fluconazole treatment for vulvovaginal candidiasis during pregnancy.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Infant, Newborn; M | 1997 |
Congenital anomalies and fluconazole.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Antifungal Agents; Candidiasis, Vulvo | 1997 |
[Maternofetal disseminated candidiasis and high-grade prematurity].
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Infant, Newborn; | 1997 |
Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient.
Topics: Abnormalities, Multiple; Adult; Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; | 1997 |
Fluconazole teratogenicity.
Topics: Abnormalities, Drug-Induced; Adult; Female; Fertilization; Fluconazole; Humans; Male; Pregnancy; Pre | 1998 |
Pregnancy outcomes after maternal exposure to fluconazole.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Female; Fluconazole; Humans; Limb Deformities, Conge | 1999 |
Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Ankle Joint; Ankylosis; Craniosynostoses; Eye | 2000 |
AIDS activists force attention to fluconazole in South Africa.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Ind | 2000 |
Treatment for coccidioidomycosis in pregnancy?
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Erythema Nodosum; Female; Fluconazole; Humans | 2001 |
South Africa cuts agreement for one AIDS drug but ignores another.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cost Savings; Drug Indust | 2001 |
First women's HIV conference hears go-for-broke antiretroviral strategy.
Topics: Antifungal Agents; Antiviral Agents; CD4 Lymphocyte Count; Counseling; Female; Fluconazole; Health E | 1995 |
Candida sepsis following transcervical chorionic villi sampling.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Chorionic Villi Sampling; Diagnosis, Differ | 2001 |
Bilateral endogenous Candida endophthalmitis after induced abortion.
Topics: Abortion, Induced; Adult; Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infec | 2001 |
Congenital malformations in an infant born to a woman treated with fluconazole.
Topics: Abnormalities, Drug-Induced; Coccidioidomycosis; Congenital Abnormalities; Female; Fluconazole; Huma | 1992 |
Vulvovaginal candidiasis refractory to treatment with fluconazole.
Topics: Adult; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Fertilization in Vitro; Flucon | 1992 |